Publication | Closed Access

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Jupiter TrialCardiovascular DiseaseHyperlipidemiaLdl CholesterolDyslipidemiaPublic HealthMedicineAtherosclerosisEpidemiologyC-reactive Protein